NEVVI Medicare utilization intelligence

← back

MARTIN, HOWARDMD NPI 1366421927 Clinician

Pathology · HOUSTON, TX

Specialty Pathology — from billed Medicare claims
Trained UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL SCHOOL AT DALLAS — medical school, self-reported to CMS
In practice about 29 years since medical school (class of 1997, self-reported to CMS)
Location HOUSTON, TX · NPPES registered location
Active in data Billed Medicare 2020–2024 (5 consecutive years)
Scale 26 codes billed · 33,156 disclosed services (CY2024 — most recent year in data)
Current groups

Group affiliation since 2019

20192026
SAGIS PLLC
2019–2026

The roster archive begins in 2019, so a span starting at 2019 may reach back further. Membership spans only — no volume is attributed to any group here.

NPPES registry · CMS Doctors & Clinicians registry · Medicare Part B physician/supplier claims · NPPES record last updated 2020-07

Year: 2024 · 2023 · 2022  · 2021  · 2020 

Provider overview · all codes · CY2024

The full analytics for this provider

Premium

The billed-volume positioning, practice focus, and economics behind this provider — computed on the same disclosed Medicare Part B data.

This provider's disclosed Medicare payments across all codes were in CY2024. Included with Platform.

  • Payment, service & beneficiary totals — the disclosed scale, all codes
  • Practice profile — focus & reach — top codes by share of services
  • Office vs. facility setting mix — place-of-service code split
  • Volume over five years — discrete yearly counts, no rate
  • Peer positioning — service volume — percentile among specialty peers, cohort & year disclosed
  • Peer positioning — code breadth — how many codes billed, vs peers

Peer positioning shows billed-volume and code-breadth positions among specialty peers, not measures of care (a provider's true volume position can only be higher, never lower). All figures disclosed Medicare Part B fee-for-service; volumes are personal to this NPI, not attributed to any group.

Notify me at launch → Or see a live example profile →

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
88305 Pathology examination of tissue using a microscope, intermediate complexity
80307 Testing for presence of drug, by chemistry analyzers
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms
87798 Detection test by nucleic acid for organism, amplified probe technique
88342 Special stained specimen slides to examine tissue, initial procedure
88341 Special stained specimen slides to examine tissue, each additional procedure
88312 Special stained specimen slides to identify organisms including interpretation and report
G0483 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms
G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms
G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms
88311 Preparation of tissue for examination by removing any calcium present
87481 Detection test for candida species (yeast), amplified probe technique
88304 Pathology examination of tissue using a microscope, moderately low complexity
88350 Antibody evaluation, each additional single antibody stain procedure
88313 Special stained specimen slides to examine tissue including interpretation and report
88314 Special stained specimen slides to examine tissue and frozen preparation of specimen including interpretation and report
88356 Microscopic genetic analysis of nerve tissue
88346 Antibody evaluation, initial single antibody stain procedure
88344 Special stained specimen slides to examine tissue, each multiplex procedure
87500 Detection test by nucleic acid for vancomycin resistance strep (vre), amplified probe technique
87640 Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique
87641 Detection test by nucleic acid for staphylococcus aureus, methicillin resistant (mrsa bacteria), amplified probe technique
87651 Detection test by nucleic acid for strep (streptococcus, group a), amplified probe technique
87653 Detection test by nucleic acid for strep (streptococcus, group b), amplified probe technique
88365 Genetic sequencing localization, initial procedure
88364 Genetic sequencing localization, each additional procedure

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.